The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection
- 31 January 2012
- journal article
- review article
- Published by Elsevier BV in European Journal of Cell Biology
- Vol. 91 (1), 31-35
- https://doi.org/10.1016/j.ejcb.2011.01.007
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 LinkPLoS Pathogens, 2009
- Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4 + T Cells by Using Virus-Like ParticlesJournal of Virology, 2008
- Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trialBlood, 2007
- Epstein-Barr Virus EntryJournal of Virology, 2007
- Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for TherapyPLOS ONE, 2007
- Identification of Major Histocompatibility Complex Class II-Restricted Antigens and Epitopes of the Epstein-Barr Virus by a Novel Bacterial Expression Cloning ApproachJournal of Virology, 2006
- Adoptive T‐cell transfer in cancer immunotherapyImmunology & Cell Biology, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesAnnual Review of Microbiology, 2000
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.The Journal of Experimental Medicine, 1992